Paper21366473
Long-term effects of intensive glucose lowering on cardiovascular outcomes.
ACCORD Study Group and 14 others. N Engl J Med, 2011. Cited by 765 papers, by iCite.
Cite this record
ConductScience Library. Long-term effects of intensive glucose lowering on cardiovascular outcomes. Papers, record 21366473. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21366473
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cardiovascular Diseases | Major topic |
| Diabetes Mellitus, Type 2 | Major topic |
| Glycated Hemoglobin | Major topic |
| Hypoglycemic Agents | Major topic |
| Adult | |
| Aged | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Kaplan-Meier Estimate | |
| Male | |
| Middle Aged | |
| Myocardial Infarction | |
| Proportional Hazards Models | |
| Stroke | |
| Treatment Outcome |
Source PubMed
Grants21
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| N01 HC095179 | NHLBI NIH HHS | United States | N01HC095179 | PubMed and NIH | NIH RePORTER |
| N01 HC095184 | NHLBI NIH HHS | United States | N01HC095184 | PubMed and NIH | NIH RePORTER |
| N01-HC-95180 | NHLBI NIH HHS | United States | N01HC095180 | PubMed and NIH | NIH RePORTER |
| N01 HC095178 | NHLBI NIH HHS | United States | N01HC095178 | PubMed and NIH | NIH RePORTER |
| Y1-HC-1010 | NHLBI NIH HHS | United States | PubMed | PubMed | |
| N01-HC-95184 | NHLBI NIH HHS | United States | N01HC095184 | PubMed and NIH | NIH RePORTER |
| N01 HC095182 | NHLBI NIH HHS | United States | N01HC095182 | PubMed and NIH | NIH RePORTER |
| N01-HC-95183 | NHLBI NIH HHS | United States | N01HC095183 | PubMed and NIH | NIH RePORTER |
| N01-HC-95178 | NHLBI NIH HHS | United States | N01HC095178 | PubMed and NIH | NIH RePORTER |
| N01-HC-95179 | NHLBI NIH HHS | United States | N01HC095179 | PubMed and NIH | NIH RePORTER |
| N01-HC-95181 | NHLBI NIH HHS | United States | N01HC095181 | PubMed and NIH | NIH RePORTER |
| Y1-HC-9035 | NHLBI NIH HHS | United States | PubMed | PubMed | |
| N01 HC095178 | NHLBI NIH HHS | United States | N01HC095178 | PubMed and NIH | NIH RePORTER |
| N01 HC095180 | NHLBI NIH HHS | United States | N01HC095180 | PubMed and NIH | NIH RePORTER |
| Y01 HC001010 | NHLBI NIH HHS | United States | Y01HC001010 | PubMed | NIH RePORTER |
| Y01 HC009035 | NHLBI NIH HHS | United States | Y01HC009035 | PubMed | NIH RePORTER |
| N01 HC095181 | NHLBI NIH HHS | United States | N01HC095181 | PubMed and NIH | NIH RePORTER |
| N01-HC-95182 | NHLBI NIH HHS | United States | N01HC095182 | PubMed and NIH | NIH RePORTER |
| N01 HC095183 | NHLBI NIH HHS | United States | N01HC095183 | PubMed and NIH | NIH RePORTER |
| R43HL095181 | NIH | NIH RePORTER |
Trials4
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT00000620 | Action to Control Cardiovascular Risk in Diabetes (ACCORD) | Derived from the trial | Yes | ClinicalTrials.gov |
| NCT01945268 | Influenza Vaccine To Prevent Adverse Vascular Events:Pilot | Background | ClinicalTrials.gov | |
| NCT02762851 | Influenza Vaccine To Prevent Adverse Vascular Events (RCT-IVVE) | Background | ClinicalTrials.gov | |
| NCT03700645 | Allopurinol in Diabetes Mellitus and Multivessel Coronary Artery Disease | Background | ClinicalTrials.gov |
Comments and corrections5
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 21544049 | Diabetes: ACCORD: 5-year outcomes of intensive glycemic control. | https://conductscience.org/library/papers/21544049 | PubMed |
| Comment in | 21576520 | ACP journal club. Intensive glucose control increased mortality and did not prevent CV events compared with standard glucose control in type 2 diabetes. | https://conductscience.org/library/papers/21576520 | PubMed |
| Comment in | 21651403 | Intensive glucose lowering and cardiovascular outcomes. | https://conductscience.org/library/papers/21651403 | PubMed |
| Comment in | 21651404 | Intensive glucose lowering and cardiovascular outcomes. | https://conductscience.org/library/papers/21651404 | PubMed |
| Comment in | 22106337 | Intensive glucose lowering (HbA1c target<6.0%) for people with type 2 diabetes increases mortality. | https://conductscience.org/library/papers/22106337 | PubMed |
References15
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20228401 | Effects of intensive blood-pressure control in type 2 diabetes mellitus. | N Engl J Med | 2010 | https://conductscience.org/library/papers/20228401 | PubMed |
| 2 | 20228404 | Effects of combination lipid therapy in type 2 diabetes mellitus. | N Engl J Med | 2010 | https://conductscience.org/library/papers/20228404 | PubMed |
| 3 | 20061360 | The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study. | BMJ | 2010 | https://conductscience.org/library/papers/20061360 | PubMed |
| 4 | 18539917 | Effects of intensive glucose lowering in type 2 diabetes. | N Engl J Med | 2008 | https://conductscience.org/library/papers/18539917 | PubMed |
| 5 | 17599423 | Glycemia treatment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. | Am J Cardiol | 2007 | https://conductscience.org/library/papers/17599423 | PubMed |
| 6 | 20103550 | Effect of intensive compared with standard glycemia treatment strategies on mortality by baseline subgroup characteristics: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. | Diabetes Care | 2010 | https://conductscience.org/library/papers/20103550 | PubMed |
| 7 | 18695086 | The hemoglobin A1c level as a progressive risk factor for cardiovascular death, hospitalization for heart failure, or death in patients with chronic heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. | Arch Intern Med | 2008 | https://conductscience.org/library/papers/18695086 | PubMed |
| 8 | 20200384 | Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. | N Engl J Med | 2010 | https://conductscience.org/library/papers/20200384 | PubMed |
| 9 | 18784090 | 10-year follow-up of intensive glucose control in type 2 diabetes. | N Engl J Med | 2008 | https://conductscience.org/library/papers/18784090 | PubMed |
| 10 | 20427682 | Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial. | Diabetes Care | 2010 | https://conductscience.org/library/papers/20427682 | PubMed |
| 11 | 20061358 | The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study. | BMJ | 2010 | https://conductscience.org/library/papers/20061358 | PubMed |
| 12 | 18043905 | HbA1c measured in stored erythrocytes and mortality rate among middle-aged and older women. | Diabetologia | 2008 | https://conductscience.org/library/papers/18043905 | PubMed |
| 13 | 16371403 | Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. | BMJ | 2006 | https://conductscience.org/library/papers/16371403 | PubMed |
| 14 | 20008761 | Comorbidity affects the relationship between glycemic control and cardiovascular outcomes in diabetes: a cohort study. | Ann Intern Med | 2009 | https://conductscience.org/library/papers/20008761 | PubMed |
| 15 | 16157837 | Glycemic control and coronary heart disease risk in persons with and without diabetes: the atherosclerosis risk in communities study. | Arch Intern Med | 2005 | https://conductscience.org/library/papers/16157837 | PubMed |
Cited by389
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 765 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42568448 | Prognostic value of the cardiometabolic index for cardiovascular outcomes in patients with type 2 diabetes mellitus. | Front Nutr | 2026 | https://conductscience.org/library/papers/42568448 | PubMed |
| 42471914 | Associations of glycated hemoglobin with etiology, lesions, and outcome of ischemic stroke: Japan Stroke Data Bank. | eNeurologicalSci | 2026 | https://conductscience.org/library/papers/42471914 | PubMed |
| 42375334 | Intensive blood pressure control in type 2 diabetes: a meta-analysis of randomized controlled trials. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42375334 | PubMed |
| 41827204 | Diabetes Mellitus as an Integrated Microbiome, Immune, and Metabolic Disorder with Clinical Implications for Multisystem Complications and Public Health. | J Clin Med | 2026 | https://conductscience.org/library/papers/41827204 | PubMed |
| 41622209 | Association of fenofibrate therapy with cardiovascular events and mortality in diabetes patients with early-diagnosed hyperlipidemia. | Lipids Health Dis | 2026 | https://conductscience.org/library/papers/41622209 | PubMed |
| 41489606 | Trained Immunity and Cardiovascular Risk: An Immunological Perspective. | Immunol Rev | 2026 | https://conductscience.org/library/papers/41489606 | PubMed |
| 41459091 | BRI shows stronger association than BMI for MACE in patients with T2DM: insights from the ACCORD study. | Front Nutr | 2025 | https://conductscience.org/library/papers/41459091 | PubMed |
| 41408264 | Associations and predictive value of weight-adjusted waist index for cardiovascular outcomes in type 2 diabetes: evidence from the ACCORD study. | Nutr J | 2025 | https://conductscience.org/library/papers/41408264 | PubMed |
| 41243295 | Bridging Evidence and Practice: A Consensus Statement from the Korean Diabetes Association on Diabetes Screening, Pharmacological Treatment and Severe Diabetes. | Diabetes Metab J | 2025 | https://conductscience.org/library/papers/41243295 | PubMed |
| 41127917 | Development of a Novel Machine Learning Method for Estimation of Life-Long Chronic Disease Progression and Its Application to Type 2 Diabetes. | Clin Transl Sci | 2025 | https://conductscience.org/library/papers/41127917 | PubMed |
| 41078062 | Depressive symptoms and hypoglycaemic risk in individuals with type 2 diabetes mellitus: insights from the ACCORD-HRQL study. | BJPsych Open | 2025 | https://conductscience.org/library/papers/41078062 | PubMed |
| 41071620 | Joslin Kidney Panel of Circulating Proteins: A Tool for ESKD Risk Discrimination and Individualized Diabetic Kidney Disease Treatment. | Clin J Am Soc Nephrol | 2026 | https://conductscience.org/library/papers/41071620 | PubMed |
| 40933374 | Comparative effectiveness and safety of sodium-glucose cotransporter 2 inhibitors vs glucagon-like peptide 1 receptor agonists in elderly patients with type 2 diabetes mellitus: a meta-analysis. | Front Endocrinol (Lausanne) | 2025 | https://conductscience.org/library/papers/40933374 | PubMed |
| 40868889 | Immune Dysregulation Connecting Type 2 Diabetes and Cardiovascular Complications. | Life (Basel) | 2025 | https://conductscience.org/library/papers/40868889 | PubMed |
| 40837332 | Triglyceride glucose-body mass index is associated with cardiovascular outcomes and overall mortality in type-2 diabetes mellitus patients. | World J Diabetes | 2025 | https://conductscience.org/library/papers/40837332 | PubMed |
| 40782797 | Inflammation reprogramming and immunomodulation: Next-generation treatments for atherosclerosis. | Cell Rep Med | 2025 | https://conductscience.org/library/papers/40782797 | PubMed |
| 40712766 | Diabetic Retinopathy Incidence, Progression, and Health-Related Quality of Life From the ACCORD Trial. | Am J Ophthalmol | 2025 | https://conductscience.org/library/papers/40712766 | PubMed |
| 40674363 | Association between estimated glucose disposal rate and major adverse cardiovascular events in patients with type 2 diabetes. | PLoS One | 2025 | https://conductscience.org/library/papers/40674363 | PubMed |
| 40628839 | Association and predictive value of the triglyceride glucose-weight adjusted waist index for cardiovascular outcomes in patients with type 2 diabetes. | Sci Rep | 2025 | https://conductscience.org/library/papers/40628839 | PubMed |
| 40603602 | PowerAI-Diabetes: Review of glycemic and lipid variability to predict cardiovascular events in Chinese diabetic population. | NPJ Metab Health Dis | 2024 | https://conductscience.org/library/papers/40603602 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| INS | 3630 | PubTator's text mining | https://conductscience.org/library/genes/3630 |
Source NCBI Gene
Drugs2
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets | Source |
|---|---|---|---|---|---|
| SIMVASTATIN | CHEMBL1064 | Derived from the trial | 1 | https://conductscience.org/library/drugs/CHEMBL1064 | ChEMBL |
| FENOFIBRATE | CHEMBL672 | Derived from the trial | 1 | https://conductscience.org/library/drugs/CHEMBL672 | ChEMBL |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21366473
GET https://conductscience.org/api/papers/v1/21366473/grants?page=2